302 related articles for article (PubMed ID: 19926634)
1. Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Zufferey PJ; Miquet M; Quenet S; Martin P; Adam P; Albaladejo P; Mismetti P; Molliex S;
Br J Anaesth; 2010 Jan; 104(1):23-30. PubMed ID: 19926634
[TBL] [Abstract][Full Text] [Related]
2. Intravenous Tranexamic Acid Bolus plus Infusion Is Not More Effective than a Single Bolus in Primary Hip Arthroplasty: A Randomized Controlled Trial.
Zufferey PJ; Lanoiselée J; Chapelle C; Borisov DB; Bien JY; Lambert P; Philippot R; Molliex S; Delavenne X;
Anesthesiology; 2017 Sep; 127(3):413-422. PubMed ID: 28692467
[TBL] [Abstract][Full Text] [Related]
3. Ferric derisomaltose and tranexamic acid, combined or alone, for reducing blood transfusion in patients with hip fracture (the HiFIT trial): a multicentre, 2 × 2 factorial, randomised, double-blind, controlled trial.
Lasocki S; Capdevila X; Vielle B; Bijok B; Lahlou-Casulli M; Collange V; Grillot N; Danguy des Deserts M; Duchalais A; Delannoy B; Drugeon B; Bouzat P; David JS; Rony L; Loupec T; Léger M; Rineau E; ;
Lancet Haematol; 2023 Sep; 10(9):e747-e755. PubMed ID: 37524101
[TBL] [Abstract][Full Text] [Related]
4. Tranexamic acid in hip fracture patients: a protocol for a randomised, placebo controlled trial on the efficacy of tranexamic acid in reducing blood loss in hip fracture patients.
Gausden EB; Garner MR; Warner SJ; Levack A; Nellestein AM; Tedore T; Flores E; Lorich DG
BMJ Open; 2016 Jun; 6(6):e010676. PubMed ID: 27329438
[TBL] [Abstract][Full Text] [Related]
5. Single-dose tranexamic acid in advanced ovarian cancer surgery reduces blood loss and transfusions: double-blind placebo-controlled randomized multicenter study.
Lundin ES; Johansson T; Zachrisson H; Leandersson U; Bäckman F; Falknäs L; Kjølhede P
Acta Obstet Gynecol Scand; 2014 Apr; 93(4):335-44. PubMed ID: 24428857
[TBL] [Abstract][Full Text] [Related]
6. Multiple boluses of intravenous tranexamic acid to reduce hidden blood loss and the inflammatory response following enhanced-recovery primary total hip arthroplasty: a randomised clinical trial.
Xie J; Hu Q; Ma J; Huang Q; Pei F
Bone Joint J; 2017 Nov; 99-B(11):1442-1449. PubMed ID: 29092982
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of a patient blood management protocol on reduction of allogeneic red blood cell transfusions in orthopedic surgery.
Polanco-García M; Capielo AM; Miret X; Chamero A; Sainz J; Revilla E; Guinjoan A; Arranz T
Med Clin (Barc); 2019 Feb; 152(3):90-97. PubMed ID: 29887176
[TBL] [Abstract][Full Text] [Related]
8. Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement: a randomized controlled trial (TRANX-H).
Alshryda S; Mason J; Sarda P; Nargol A; Cooke N; Ahmad H; Tang S; Logishetty R; Vaghela M; McPartlin L; Hungin AP
J Bone Joint Surg Am; 2013 Nov; 95(21):1969-74. PubMed ID: 24196467
[TBL] [Abstract][Full Text] [Related]
9. Single dose of tranexamic acid effectively reduces blood loss and transfusion rates in elderly patients undergoing surgery for hip fracture: a randomized controlled trial.
Nikolaou VS; Masouros P; Floros T; Chronopoulos E; Skertsou M; Babis GC
Bone Joint J; 2021 Mar; 103-B(3):442-448. PubMed ID: 33641430
[TBL] [Abstract][Full Text] [Related]
10. Tranexamic acid safely reduces hidden blood loss in patients undergoing intertrochanteric fracture surgery: a randomized controlled trial.
Zhang S; Xiao C; Yu W; Long N; He F; Cai P; Luo K; Jiang Y
Eur J Trauma Emerg Surg; 2022 Apr; 48(2):731-741. PubMed ID: 32415365
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial.
Camarasa MA; Ollé G; Serra-Prat M; Martín A; Sánchez M; Ricós P; Pérez A; Opisso L
Br J Anaesth; 2006 May; 96(5):576-82. PubMed ID: 16531440
[TBL] [Abstract][Full Text] [Related]
12. Combined use of intravenous and topical versus intravenous tranexamic acid in primary total knee and hip arthroplasty: a meta-analysis of randomised controlled trials.
Li JF; Li H; Zhao H; Wang J; Liu S; Song Y; Wu HF
J Orthop Surg Res; 2017 Feb; 12(1):22. PubMed ID: 28153031
[TBL] [Abstract][Full Text] [Related]
13. Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip: results of a randomised controlled trial.
Tengberg PT; Foss NB; Palm H; Kallemose T; Troelsen A
Bone Joint J; 2016 Jun; 98-B(6):747-53. PubMed ID: 27235515
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of tranexamic acid in hip hemiarthroplasty surgery: an observational cohort study.
Lee C; Freeman R; Edmondson M; Rogers BA
Injury; 2015 Oct; 46(10):1978-82. PubMed ID: 26190627
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of perioperative tranexamic acid in elderly patients undergoing trochanteric fracture surgery: a randomised controlled trial.
Chen F; Jiang Z; Li M; Zhu X
Hong Kong Med J; 2019 Apr; 25(2):120-126. PubMed ID: 30919809
[TBL] [Abstract][Full Text] [Related]
16. Tranexamic acid reduces blood loss and transfusion in reoperative cardiac surgery.
Dryden PJ; O'Connor JP; Jamieson WR; Reid I; Ansley D; Sadeghi H; Burr LH; Munro AI; Merrick PM
Can J Anaesth; 1997 Sep; 44(9):934-41. PubMed ID: 9305556
[TBL] [Abstract][Full Text] [Related]
17. The Michigan Experience with Safety and Effectiveness of Tranexamic Acid Use in Hip and Knee Arthroplasty.
Hallstrom B; Singal B; Cowen ME; Roberts KC; Hughes RE
J Bone Joint Surg Am; 2016 Oct; 98(19):1646-1655. PubMed ID: 27707851
[TBL] [Abstract][Full Text] [Related]
18. Low-volume formulation of intra-articular tranexamic acid, 25-ml tranexamic acid (2.5 g) plus 20-ml saline, is effective in decreasing blood transfusion rate in primary total knee replacement even without preoperative haemoglobin optimization.
Rodriguez-Merchan EC; Ortega-Andreu M; Padilla-Eguiluz NG; Gomez-Cardero P; Martinez-Lloreda Á; Gomez-Barrena E
Blood Coagul Fibrinolysis; 2016 Sep; 27(6):660-6. PubMed ID: 27058218
[TBL] [Abstract][Full Text] [Related]
19. Study protocol for a multicentre, 2×2 factorial, randomised, controlled trial evaluating the interest of intravenous iron and tranexamic acid to reduce blood transfusion in hip fracture patients (the HiFIT study).
Lasocki S; Loupec T; Parot-Schinkel E; Vielle B; Danguy des Déserts M; Roquilly A; Lahlou-Casulli M; Collange V; Desebbe O; Duchalais A; Drugeon B; Bouzat P; Garrigue D; Mounet B; Hamard F; David JS; Leger M; Rineau E;
BMJ Open; 2021 Jan; 11(1):e040273. PubMed ID: 33455926
[TBL] [Abstract][Full Text] [Related]
20. Tranexamic acid reduces the need for allogenic red blood cell transfusions in patients undergoing total hip replacement.
Lemay E; Guay J; Côté C; Roy A
Can J Anaesth; 2004 Jan; 51(1):31-7. PubMed ID: 14709457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
